Advertisement

Topics

Lack of robust post-approval studies under FDA system

06:09 EDT 30 Jun 2017 | Pharmaceutical Journal

Review of drugs approved on the basis of limited evidence concludes that stricter rules are needed for post-approval studies.

Original Article: Lack of robust post-approval studies under FDA system

NEXT ARTICLE

More From BioPortfolio on "Lack of robust post-approval studies under FDA system"

Advertisement
Quick Search
Advertisement
Advertisement